HK Stock Market Move | Hangzhou Tigermed Consulting (03347) rose more than 7%, with net profit attributable to the parent increasing by 98.73% year-on-year in the third quarter.

date
09:32 30/10/2025
avatar
GMT Eight
Tiger Pharmaceuticals (03347) surged more than 7%, as of the time of writing, it was up 7.7% to HK$46.44, with a trading volume of HK$21.36 million.
Hangzhou Tigermed Consulting (03347) rose more than 7%, as of press time, it rose by 7.7%, to 46.44 Hong Kong dollars, with a turnover of 213.607 million Hong Kong dollars. In terms of news, Hangzhou Tigermed Consulting released its third quarter report for 2025, with the group earning operating income of 5.26 billion yuan in the first three quarters, a decrease of 0.82% year-on-year; net profit attributable to the parent company was 1.02 billion yuan, an increase of 25.45% year-on-year. Looking at the third quarter alone, the company achieved operating income of 1.75 billion yuan, an increase of 3.86% year-on-year; net profit attributable to the parent company was 637 million yuan, an increase of 98.73% year-on-year.